Abstract
BackgroundA key barrier to effective immunotherapy for cancer is the immunosuppressive tumor microenvironment (TME) characterized by infiltrating regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSC). While depletion of immune-suppressive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have